<DOC>
	<DOCNO>NCT01409993</DOCNO>
	<brief_summary>The purpose study determine effect chronic PDE5 inhibitor therapy glucose metabolism person prediabetes .</brief_summary>
	<brief_title>Renin-Angiotensin Fibrinolysis Humans : Effect Long-Term PDE5 Inhibition Glucose Homeostasis</brief_title>
	<detailed_description />
	<mesh_term>Glucose Intolerance</mesh_term>
	<mesh_term>Sildenafil Citrate</mesh_term>
	<criteria>Inclusion criterion : Age &gt; 18 year BMI &gt; 25 kg/M2 ( &gt; 23 kg/M2 among Asian Americans ) Elevated fast plasma glucose ( 100125 mg/dL ) IGT ( 2 hour plasma glucose 140199 mg/dL ) OR metabolic syndrome and/or hemoglobin A1c 5.76.4 % Exclusion criterion : Diabetes type 1 type 2 , define fast glucose 126 mg/dL great , two hour plasma glucose 200 mg/dL great , use antidiabetic medication . The use nitrate disease might require use nitrate . The use potent CYP3A4 inhibitor . subject participated weightreduction program last 6 month whose weight increase decreased 2 kg precede 6 month . Pregnancy . Women childbearing potential require undergone tubal ligation use barrier method birth control . Breastfeeding . Cardiovascular disease myocardial infarction within 6 month prior enrollment , presence angina pectoris , significant arrhythmia , congestive heart failure ( LV hypertrophy acceptable ) , deep vein thrombosis , pulmonary embolism , second third degree heart block , mitral valve stenosis , aortic stenosis hypertrophic cardiomyopathy . Treatment anticoagulant . Treatment metformin . History serious neurologic disease cerebral hemorrhage , stroke , transient ischemic attack . History presence immunological hematological disorder . Diagnosis asthma . Clinically significant gastrointestinal impairment could interfere drug absorption . Impaired hepatic function ( aspartate amino transaminase [ AST ] and/or alanine amino . transaminase [ ALT ] &gt; 1.5 x upper limit normal range ) Impaired renal function ( serum creatinine &gt; 1.5 mg/dl ) . Hematocrit &lt; 35 % . Any underlying acute disease require regular medication could possibly pose threat subject make implementation protocol interpretation study result difficult . Treatment chronic systemic glucocorticoid therapy ( 7 consecutive day 1 month ) . Treatment lithium salt . History alcohol drug abuse . Treatment investigational drug 1 month precede study . Mental condition render subject unable understand nature , scope possible consequence study . Inability comply protocol , e.g . uncooperative attitude , inability return followup visit , unlikelihood completing study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>BMI great 25</keyword>
	<keyword>Elevated fast blood sugar ( 100-125mg/dL )</keyword>
</DOC>